Aberrant expression of LAMC1 has been associated with various biological and clinical characteristics in several cancers, including gastric cancer (53), hepatocellular carcinoma (54), renal cell carcinoma (55), colorectal cancer (56), and lung cancer (57). Here, LAMC1 is linked to lung carcinoma.